Knowledge (XXG)

Affinity chromatography

Source đź“ť

299: 2474: 549:, is used. GST has an affinity for glutathione which is commercially available immobilized as glutathione agarose. During elution, excess glutathione is used to displace the tagged protein. CL7 has an affinity and specificity for Immunity Protein 7 (Im7) which is commercially available immobilized as Im7 agarose resin. For elution, an active and site-specific protease is applied to the Im7 resin to release the tag-free protein. 2254: 398:
of that antigen. This is also known as Immunoaffinity Chromatography. For example, if an organism is immunised against a GST-fusion protein it will produce antibodies against the fusion-protein, and possibly antibodies against the GST tag as well. The protein can then be covalently coupled to a solid support such as agarose and used as an affinity ligand in purifications of antibody from immune serum.
586:
affinity matrix. p-aminobenyl-1-thio-β-D-galactopyranosyl agarose is used as the affinity matrix because it contains a galactopyranosyl group, which serves as a good substrate analog for E. coli β-Galactosidase. This property allows the enzyme to bind to the stationary phase of the affinity matrix and β-Galactosidase is eluted by adding increasing concentrations of salt to the column.
342:(PCC). The resin costs per amount of produced product can thus be drastically reduced. Since one column can always be eluted and regenerated while the other column is loaded, already two columns are sufficient to make full use of the advantages. Additional columns can give additional flexibility for elution and regeneration times, at the cost of additional equipment and resin costs. 482: 114:
biomolecules by disrupting their weaker interactions with the stationary phase, while the biomolecules of interest will remain bound. Target biomolecules may then be removed by applying a so-called elution buffer, which disrupts interactions between the bound target biomolecules and the ligand. The target molecule is thus recovered in the eluting solution.
315:
are usually done at ambient pressure. Alternatively, binding may be achieved using a batch treatment, for example, by adding the initial mixture to the solid phase in a vessel, mixing, separating the solid phase, removing the liquid phase, washing, re-centrifuging, adding the elution buffer, re-centrifuging and removing the elute.
307: 653:
based on their different weak affinities to an immobilized target. The higher affinity a compound has towards the target, the longer it remains in the separation unit, and this will be expressed as a longer retention time. The affinity measure and ranking of affinity can be achieved by processing the
397:
Another use for the procedure is the affinity purification of antibodies from blood serum. If the serum is known to contain antibodies against a specific antigen (for example if the serum comes from an organism immunized against the antigen concerned) then it can be used for the affinity purification
326:
A third method, expanded bed absorption, which combines the advantages of the two methods mentioned above, has also been developed. The solid phase particles are placed in a column where liquid phase is pumped in from the bottom and exits at the top. The gravity of the particles ensure that the solid
314:
Binding to the solid phase may be achieved by column chromatography whereby the solid medium is packed onto a column, the initial mixture run through the column to allow settling, a wash buffer run through the column and the elution buffer subsequently applied to the column and collected. These steps
585:
Another use for affinity chromatography is the purification of specific proteins using a gel matrix that is unique to a specific protein. For example, the purification of E. coli β-galactosidase is accomplished by affinity chromatography using p-aminobenyl-1-thio-β-D-galactopyranosyl agarose as the
337:
More recently, setups employing more than one column in series have been developed. The advantage compared to single column setups is that the resin material can be fully loaded since non-binding product is directly passed on to a consecutive column with fresh column material. These chromatographic
117:
Affinity chromatography does not require the molecular weight, charge, hydrophobicity, or other physical properties of the analyte of interest to be known, although knowledge of its binding properties is useful in the design of a separation protocol. Types of binding interactions commonly exploited
456:
Immunoaffinity chromatography is also the basis for immunochromatographic test (ICT) strips, which provide a rapid means of diagnosis in patient care. Using ICT, a technician can make a determination at a patient's bedside, without the need for a laboratory. ICT detection is highly specific to the
382:
Immunoaffinity media (detailed below) utilizes antigens' and antibodies' high specificity to separate; immobilized metal affinity chromatography is detailed further below and uses interactions between metal ions and proteins (usually specially tagged) to separate; nucleotide/coenzyme that works to
353:
By using affinity chromatography, one can separate proteins that bind to a certain fragment from proteins that do not bind that specific fragment. Because this technique of purification relies on the biological properties of the protein needed, it is a useful technique and proteins can be purified
465:
Immobilized metal ion affinity chromatography (IMAC) is based on the specific coordinate covalent bond of amino acids, particularly histidine, to metals. This technique works by allowing proteins with an affinity for metal ions to be retained in a column containing immobilized metal ions, such as
410:
or phosphate buffer, to neutralize the low pH elution buffer and halt any degradation of the antibody's activity. This is a nice example as affinity purification is used to purify the initial GST-fusion protein, to remove the undesirable anti-GST antibodies from the serum and to purify the target
401:
For thoroughness, the GST protein and the GST-fusion protein can each be coupled separately. The serum is initially allowed to bind to the GST affinity matrix. This will remove antibodies against the GST part of the fusion protein. The serum is then separated from the solid support and allowed to
113:
with which the ligand can react, forming stable covalent bonds. The stationary phase is first loaded into a column to which the mobile phase is introduced. Molecules that bind to the ligand will remain associated with the stationary phase. A wash buffer is then applied to remove non-target
375:
is nonspecific but mimics biological substrates and proteins. Glutathione is useful for separation of GST tagged recombinant proteins. Heparin is a generalized affinity ligand, and it is most useful for separation of plasma coagulation proteins, along with nucleic acid enzymes and lipases
626:-macroglobulin contamination, when performing mass spectrometry. In affinity purification of serum albumin, the stationary used for collecting or attracting serum proteins can be Cibacron Blue-Sepharose. Then the serum proteins can be eluted from the adsorbent with a buffer containing 568:
are proteins which can bind specific alpha-D-mannose and alpha-D-glucose carbohydrate molecules. Some common carbohydrate molecules that is used in lectin affinity chromatography are Con A-Sepharose and WGA-agarose. Another example of a lectin is wheat germ agglutinin which binds
452:
Immunoaffinity chromatography with monoclonal antibodies immobilized on monolithic column has been successfully used to capture extracellular vesicles (e.g., exosomes and exomeres) from human blood plasma by targeting tetraspanins and integrins found on the surface of the EVs.
429:
functional group which allows the peptide to be easily conjugated to a carrier protein (e.g. Keyhole limpet hemocyanin (KLH)). The same cysteine-containing peptide is also immobilized onto an agarose resin through the cysteine residue and is then used to purify the antibody.
714:
Aizpurua-Olaizola, Oier; Sastre Torano, Javier; Pukin, Aliaksei; Fu, Ou; Boons, Geert Jan; de Jong, Gerhardus J.; Pieters, Roland J. (January 2018). "Affinity capillary electrophoresis for the assessment of binding affinity of carbohydrate-based cholera toxin inhibitors".
597:
from E. coli can be purified using a DEAE-Cellulose matrix. A. phosphatase has a slight negative charge, allowing it to weakly bind to the positively charged amine groups in the matrix. The enzyme can then be eluted out by adding buffer with higher salt concentrations.
1841:
Meiby, E.; Simmonite, H.; Le Strat, L.; Davis, B.; Matassova, N.; Moore, J. D.; Mrosek, M.; Murray, J.; Hubbard, R. E.; Ohlson, S. (2013). "Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90".
466:
cobalt, nickel, or copper for the purification of histidine-containing proteins or peptides, iron, zinc or gallium for the purification of phosphorylated proteins or peptides. Many naturally occurring proteins do not have an affinity for metal ions, therefore
1213:
Multia E, Tear CJ, Palviainen M, et al. (December 2019). "Fast isolation of highly specific population of platelet-derived extracellular vesicles from blood plasma by affinity monolithic column, immobilized with anti-human CD61 antibody".
322:
The ligands used in affinity chromatography are obtained from both organic and inorganic sources. Examples of biological sources are serum proteins, lectins and antibodies. Inorganic sources are moronic acid, metal chelates and triazine dyes.
1130:
Thompson, Nancy E.; Foley, Katherine M.; Stalder, Elizabeth S.; Burgess, Richard R. (2009). "Chapter 28 Identification, Production, and Use of Polyol-Responsive Monoclonal Antibodies for Immunoaffinity Chromatography".
362:
Many different affinity media exist for a variety of possible uses. Briefly, they are (generalized) activated/functionalized that work as a functional spacer, support matrix, and eliminates handling of toxic reagents.
366:
Amino acid media is used with a variety of serum proteins, proteins, peptides, and enzymes, as well as rRNA and dsDNA. Avidin biotin media is used in the purification process of biotin/avidin and their derivatives.
318:
Sometimes a hybrid method is employed such that the binding is done by the batch method, but the solid phase with the target molecule bound is packed onto a column and washing and elution are done on the column.
544:
ions which have been immobilized by forming coordinate covalent bonds with a chelator incorporated in the stationary phase. For elution, an excess amount of a compound able to act as a metal ion ligand, such as
402:
bind to the GST-fusion protein matrix. This allows any antibodies that recognize the antigen to be captured on the solid support. Elution of the antibodies of interest is most often achieved using a low
370:
Carbohydrate bonding is most often used with glycoproteins or any other carbohydrate-containing substance; carbohydrate is used with lectins, glycoproteins, or any other carbohydrate metabolite protein.
1468:
Vassylyeva, Marina N.; Klyuyev, Sergiy; Vassylyev, Alexey D.; Wesson, Hunter; Zhang, Zhuo; Renfrow, Matthew B.; Wang, Hengbin; Higgins, N. Patrick; Chow, Louise T.; Vassylyev, Dmitry G. (27 June 2017).
414:
Monoclonal antibodies can also be selected to bind proteins with great specificity, where protein is released under fairly gentle conditions. This can become of use for further research in the future.
922:
Baur, Daniel; Angarita, Monica; Müller-Späth, Thomas; Steinebach, Fabian; Morbidelli, Massimo (2016). "Comparison of batch and continuous multi-column protein A capture processes by optimal design".
1717:
Naval, Javier; Calvo, Miguel; Lampreave, Fermin; Piñeiro, Andrés (1 January 1983). "Affinity chromatography of serum albumin: An illustrative laboratory experiment on biomolecular interactions".
1643: 2171: 1803:
Duong-Thi, M. D.; Meiby, E.; Bergström, M.; Fex, T.; Isaksson, R.; Ohlson, S. (2011). "Weak affinity chromatography as a new approach for fragment screening in drug discovery".
350:
Affinity chromatography can be used in a number of applications, including nucleic acid purification, protein purification from cell free extracts, and purification from blood.
504:
in order to aid their purification. The protein may have been genetically modified so as to allow it to be selected for affinity binding; this is known as a fusion protein.
2290: 389:
Speciality media are designed for a specific class or type of protein/co enzyme; this type of media will only work to separate a specific protein or coenzyme.
577:
from another glycoform. Although there are various ways to perform lectin affinity chromatography, the goal is extract a sugar ligand of the desired protein.
2166: 2638: 1061:
Mahmoudi Gomari, Mohammad; Saraygord-Afshari, Neda; Farsimadan, Marziye; Rostami, Neda; Aghamiri, Shahin; Farajollahi, Mohammad M. (1 December 2020).
2161: 2029: 1351:
J. D. Muller; C. R. Wilks; K. J. O'Riley; R. J. Condron; R. Bull; A. Mateczun (2004). "Specificity of an immunochromatographic test for anthrax".
339: 386:
Nucleic acids function to trap mRNA, DNA, rRNA, and other nucleic acids/oligonucleotides. Protein A/G method is used to purify immunoglobulins.
2120: 2115: 2100: 1647: 1409: 881: 41:
interaction between the biomolecule and another substance. The specific type of binding interaction depends on the biomolecule of interest;
793: 500:
Possibly the most common use of affinity chromatography is for the purification of recombinant proteins. Proteins with a known affinity are
1980: 1116: 610:. Clinical adaptations have applied this type of chromatography for use in determining long term assessment of diabetic patients through 334:
by changing salt concentrations, pH, pI, charge and ionic strength directly or through a gradient to resolve the particles of interest.
2283: 1556: 1037: 372: 89:
Affinity chromatography has the advantage of specific binding interactions between the analyte of interest (normally dissolved in the
73:
binding interactions are frequently exploited for isolation of various biomolecules. Affinity chromatography is useful for its high
1693: 1335: 1148: 906: 856: 828: 777: 678: 2448: 2105: 1063:"Opportunities and challenges of the tag-assisted protein purification techniques: Applications in the pharmaceutical industry" 2458: 2145: 2438: 2276: 2135: 2130: 1353: 2413: 2022: 654:
obtained retention times of analyzed compounds. Affinity chromatography is part of a larger suite of techniques used in
285: 94: 2488: 2473: 2238: 2231: 2085: 189: 78: 2508: 2075: 467: 97:). In a typical affinity chromatography experiment, the ligand is attached to a solid, insoluble matrix—usually a 1390:"Direct Capture of His6-Tagged Proteins Using Megaporous Cryogels Developed for Metal-Ion Affinity Chromatography" 74: 2548: 2433: 2224: 2140: 2054: 1999: 248: 2318: 2591: 1433:
Gaberc-Porekar, Vladka K.; Menart, Viktor (2001). "Perspectives of immobilized-metal affinity chromatography".
645:) is an affinity chromatography technique for affinity screening in drug development. WAC is an affinity-based 54: 681:(PPI) targets. WAC has been shown to be more effective than established methods for fragment based screening. 606:
Boronate affinity chromatography consists of using boronic acid or boronates to elute and quantify amounts of
485:
A chromatography column containing nickel-agarose beads used for purification of proteins with histidine tags
2643: 2358: 2257: 2049: 2015: 622:
Affinity purification of albumin and macroglobulin contamination is helpful in removing excess albumin and α
2453: 2383: 2197: 1062: 2573: 2568: 2373: 2333: 2187: 2090: 2080: 1277:"Automated On-Line Isolation and Fractionation System for Nanosized Biomacromolecules from Human Plasma" 62: 58: 2523: 2408: 2353: 2207: 2125: 1919: 1761: 1482: 1223: 897:
Fanali, Salvatore; Haddad, Paul R.; Poole, Colin F.; Schoenmakers, Peter; Lloyd, David, eds. (2013).
594: 978: 2343: 2192: 674: 611: 434: 1600: 379:
Hydrophobic interaction media are most commonly used to target free carboxyl groups and proteins.
298: 2403: 2299: 2202: 2110: 2095: 1785: 1578: 1257: 1098: 957: 750: 425:
residue is added at either the N- or C-terminus of the peptide. This cysteine residue contains a
2543: 2418: 2378: 1973: 1947: 1859: 1820: 1777: 1734: 1699: 1689: 1625: 1570: 1562: 1552: 1518: 1500: 1471:"Efficient, ultra-high-affinity chromatography in a one-step purification of complex proteins" 1450: 1415: 1405: 1370: 1331: 1308: 1249: 1195: 1154: 1144: 1090: 1082: 1043: 1033: 949: 902: 877: 852: 824: 773: 742: 690: 650: 490: 110: 38: 1994: 1937: 1927: 1851: 1812: 1769: 1726: 1615: 1544: 1508: 1490: 1442: 1397: 1362: 1298: 1288: 1239: 1231: 1185: 1136: 1074: 1008: 939: 931: 732: 724: 204: 141: 1894:
Affinity chromatography is a novel technique which was conceived by Cuatrecasas and Wilchek
474:
the protein of interest include changing the pH, or adding a competitive molecule, such as
2601: 2538: 2463: 2443: 2423: 2398: 2338: 1396:. Methods in Molecular Biology. Vol. 1286. New York: Humana Press. pp. 201–212. 655: 1923: 1765: 1486: 1227: 2617: 2328: 2038: 1513: 1470: 1366: 1303: 1276: 646: 565: 438: 417:
A simplified strategy is often employed to purify antibodies generated against peptide
270: 251: 174: 106: 17: 1942: 1907: 1446: 1140: 2632: 2558: 2533: 1730: 1261: 1102: 1078: 961: 754: 470:
can be used to introduce such a protein tag into the relevant gene. Methods used to
2518: 2503: 2393: 2363: 1877: 1789: 1582: 1388:
Singh, Naveen K.; DSouza, Roy N.; Bibi, Noor S.; Fernández-Lahore, Marcelo (2015).
694: 607: 570: 184: 90: 70: 1548: 1401: 1389: 1293: 2493: 2348: 1969:"Affinity Chromatography Principle, Procedure And Advance Detailed Note – 2020". 1620: 627: 513: 505: 501: 243: 34: 1912:
Proceedings of the National Academy of Sciences of the United States of America
1475:
Proceedings of the National Academy of Sciences of the United States of America
2513: 2498: 2388: 2323: 1235: 426: 280: 230: 1816: 1781: 1738: 1703: 1566: 1504: 1086: 1047: 2596: 1495: 574: 546: 521: 509: 475: 446: 442: 265: 261: 1863: 1824: 1629: 1574: 1522: 1454: 1419: 1374: 1312: 1253: 1199: 1158: 1094: 953: 935: 746: 728: 1951: 1932: 1013: 481: 2553: 2528: 2313: 944: 666: 422: 154: 118:
in affinity chromatography procedures are summarized in the table below.
46: 1244: 2428: 2268: 737: 662: 517: 471: 418: 331: 199: 159: 102: 98: 66: 42: 1855: 1190: 1173: 406:
buffer such as glycine pH 2.8. The eluate is collected into a neutral
2368: 1773: 901:. Handbooks in Separation Science. Saint Louis: Elsevier. p. 3. 670: 561: 557: 537: 529: 525: 219: 214: 169: 50: 1968: 1686:
Fundamental laboratory approaches for biochemistry and biotechnology
1671:
Fundamental Laboratory Approaches for Biochemistry and Biotechnology
770:
Fundamental Laboratory Approaches for Biochemistry and Biotechnology
564:
are used to separate components within the sample. Lectins, such as
569:
D-N-acetyl-glucosamine. The most common application is to separate
560:
affinity chromatography is a form of affinity chromatography where
421:. When the peptide antigens are produced synthetically, a terminal 2563: 1275:
Multia E, Liangsupree T, Jussila M, et al. (September 2020).
305: 297: 2007: 661:
The WAC technology is demonstrated against a number of different
541: 533: 407: 306: 122:
Typical biological interactions used in affinity chromatography
2272: 2011: 1684:
Ninfa, Alexander J.; Ballou, David P.; Benore, Marilee (2010).
1669:
Ninfa, Alexander J.; Ballou, David P.; Benore, Marilee (2006).
768:
Ninfa, Alexander J.; Ballou, David P.; Benore, Marilee (2009).
689:
Affinity chromatography was conceived and first developed by
1752:
Zopf, D.; S. Ohlson (1990). "Weak-affinity chromatography".
1601:"Affinity Chromatography: A Review of Clinical Applications" 1539:
Freeze, H. H. (May 2001). "Lectin affinity chromatography".
1328:
Point-of-care testing: principles and clinical applications
520:
binding protein (MBP), and the Colicin E7 variant CL7 tag.
403: 1908:"Selective enzyme purification by affinity chromatography" 1135:. Methods in Enzymology. Vol. 463. pp. 475–494. 851:(2nd ed.). Totowa, N.J.: Taylor & Francis Group. 823:(2nd ed.). Totowa, N.J.: Humana Press. pp. 1–2. 437:
have been purified using affinity chromatography based on
81:
of separation, compared to other chromatographic methods.
1688:(2nd ed.). Hoboken, N.J.: John Wiley. p. 240. 1906:
P Cuatrecasas; M Wilchek; C B Anfinsen (October 1968).
93:), and a binding partner or ligand (immobilized on the 327:
phase does not exit the column with the liquid phase.
383:
separate dehydrogenases, kinases, and transaminases.
1003:
Ahern, Kevin; Rajagopal, Indira (12 February 2015).
2610: 2582: 2481: 2306: 2216: 2180: 2154: 2063: 1534: 1532: 1644:"GE Healthcare Life Sciences, Immobilized lectin" 876:. New Delhi: Pathfinder Publication. p. 11. 2172:Pyrolysis–gas chromatography–mass spectrometry 973: 971: 821:Affinity Chromatography: Methods and Protocols 2284: 2023: 1836: 1834: 1543:. Vol. Chapter 9. pp. 9.1.1–9.1.9. 1330:. Berlin, Germany: Springer. pp. 71–72. 461:Immobilized metal ion affinity chromatography 8: 1594: 1592: 1007:(3rd ed.). DaVinci Press. p. 822. 794:""Introduction to Affinity Chromatography"" 302:Principle of affinity column chromatography 109:—chemically modified to introduce reactive 37:from a mixture, based on a highly specific 2291: 2277: 2269: 2030: 2016: 2008: 1133:Guide to Protein Purification, 2nd Edition 1941: 1931: 1619: 1512: 1494: 1302: 1292: 1243: 1189: 1012: 943: 842: 840: 736: 480: 120: 2167:Liquid chromatography–mass spectrometry 706: 573:from non-glycosylated proteins, or one 340:periodic counter-current chromatography 27:Purification technique for biomolecules 2116:Micellar electrokinetic chromatography 2101:High-performance liquid chromatography 1028:Grisham, Charles M. (1 January 2013). 612:analysis of their glycated hemoglobin 7: 2162:Gas chromatography–mass spectrometry 1541:Current Protocols in Protein Science 1174:"Affinity as a tool in life science" 772:(2nd ed.). Wiley. p. 133. 1673:(2nd ed.). Wiley. p. 153. 899:Liquid Chromatography: Applications 1367:10.1111/j.1751-0813.2004.tb12682.x 658:based drug target identification. 25: 1974:"What is affinity chromatography" 1032:. Brooks/Cole, Cengage Learning. 2639:Biochemical separation processes 2472: 2253: 2252: 1878:"Meir Wilchek - Wolf Foundation" 1079:10.1016/j.biotechadv.2020.107653 874:Biophysics and Molecular Biology 819:Zachariou, Michael, ed. (2008). 602:Boronate affinity chromatography 2106:Capillary electrochromatography 2146:Two-dimensional chromatography 457:microbe causing an infection. 1: 2136:Size-exclusion chromatography 2131:Reversed-phase chromatography 1447:10.1016/S0165-022X(01)00207-X 1354:Australian Veterinary Journal 1141:10.1016/s0076-6879(09)63028-7 2000:Resources in other libraries 1731:10.1016/0307-4412(83)90004-3 1549:10.1002/0471140864.ps0901s00 1402:10.1007/978-1-4939-2447-9_16 1294:10.1021/acs.analchem.0c01986 1005:Biochemistry Free & Easy 847:Bonner, Philip L.R. (2007). 800:. Bio-Rad. 14 September 2020 639:Weak affinity chromatography 634:Weak affinity chromatography 286:polyhistidine fusion protein 222:/Biotin-conjugated molecule 33:is a method of separating a 2239:Journal of Chromatography B 2232:Journal of Chromatography A 2121:Normal-phase chromatography 2086:Displacement chromatography 679:protein–protein interaction 235:Calmodulin binding partner 190:Complementary base sequence 2660: 2509:Electrostatic precipitator 2076:Argentation chromatography 618:Serum albumin purification 524:tags have an affinity for 488: 468:recombinant DNA technology 2549:Rotary vacuum-drum filter 2470: 2248: 2225:Biomedical Chromatography 2141:Thin-layer chromatography 2045: 1995:Resources in your library 1621:10.1093/clinchem/45.5.593 1435:J Biochem Biophys Methods 1392:. In Reichelt, S. (ed.). 1236:10.1016/j.aca.2019.09.022 1117:"Affinity Chromatography" 649:technique that separates 449:, derived from bacteria. 2592:Aqueous two-phase system 2414:Liquid–liquid extraction 1817:10.1016/j.ab.2011.02.022 1599:Hage, David (May 1999). 354:many folds in one step. 330:Affinity columns can be 2489:API oil–water separator 2359:Dissolved air flotation 2071:Affinity chromatography 1986:Affinity chromatography 1805:Analytical Biochemistry 1496:10.1073/pnas.1704872114 1394:Affinity Chromatography 508:include hexahistidine ( 338:processes are known as 294:Batch and column setups 31:Affinity chromatography 18:Affinity Chromatography 2454:Solid-phase extraction 2217:Prominent publications 2198:Kovats retention index 1216:Analytica Chimica Acta 1067:Biotechnology Advances 936:10.1002/biot.201500481 872:Kumar, Pranav (2018). 729:10.1002/elps.201700207 647:liquid chromatographic 516:-S-transferase (GST), 486: 358:Various affinity media 311: 303: 39:macromolecular binding 2574:Vacuum ceramic filter 2569:Sublimation apparatus 2374:Electrochromatography 2334:Cross-flow filtration 2188:Distribution constant 2091:Electrochromatography 2081:Column chromatography 1933:10.1073/pnas.61.2.636 1719:Biochemical Education 1326:Luppa, Peter (2018). 924:Biotechnology Journal 484: 435:monoclonal antibodies 309: 301: 2524:Fractionating column 2319:Acid–base extraction 2300:Separation processes 2208:Van Deemter equation 2126:Paper chromatography 1844:Analytical Chemistry 1281:Analytical Chemistry 849:Protein Purification 595:Alkaline phosphatase 590:Alkaline phosphatase 496:Recombinant proteins 310:Batch chromatography 2344:Cyclonic separation 2193:Freundlich equation 1924:1968PNAS...61..636C 1766:1990Natur.346...87Z 1487:2017PNAS..114E5138V 1481:(26): E5138–E5147. 1287:(19): 13058–13065. 1228:2019AcAC.1091..160M 123: 2404:Gravity separation 2155:Hyphenated methods 2111:Ion chromatography 2096:Gas chromatography 1608:Clinical Chemistry 651:chemical compounds 487: 312: 304: 142:Substrate analogue 121: 2626: 2625: 2544:Rapid sand filter 2439:Recrystallization 2419:Electroextraction 2379:Electrofiltration 2266: 2265: 1981:Library resources 1884:. 9 December 2018 1856:10.1021/ac400715t 1850:(14): 6756–6766. 1411:978-1-4939-2447-9 1191:10.2144/000112803 883:978-93-80473-15-4 691:Pedro Cuatrecasas 491:Polyhistidine-tag 291: 290: 111:functional groups 16:(Redirected from 2651: 2476: 2293: 2286: 2279: 2270: 2256: 2255: 2203:Retention factor 2032: 2025: 2018: 2009: 1956: 1955: 1945: 1935: 1903: 1897: 1896: 1891: 1889: 1874: 1868: 1867: 1838: 1829: 1828: 1800: 1794: 1793: 1774:10.1038/346087a0 1749: 1743: 1742: 1714: 1708: 1707: 1681: 1675: 1674: 1666: 1660: 1659: 1657: 1655: 1646:. Archived from 1640: 1634: 1633: 1623: 1605: 1596: 1587: 1586: 1536: 1527: 1526: 1516: 1498: 1465: 1459: 1458: 1441:(1–3): 335–360. 1430: 1424: 1423: 1385: 1379: 1378: 1348: 1342: 1341: 1323: 1317: 1316: 1306: 1296: 1272: 1266: 1265: 1247: 1210: 1204: 1203: 1193: 1172:UhlĂ©n M (2008). 1169: 1163: 1162: 1127: 1121: 1120: 1113: 1107: 1106: 1058: 1052: 1051: 1025: 1019: 1018: 1016: 1000: 994: 993: 991: 989: 975: 966: 965: 947: 919: 913: 912: 894: 888: 887: 869: 863: 862: 844: 835: 834: 816: 810: 809: 807: 805: 790: 784: 783: 765: 759: 758: 740: 711: 373:Dye ligand media 133:Target molecule 130:Types of ligand 124: 95:stationary phase 21: 2659: 2658: 2654: 2653: 2652: 2650: 2649: 2648: 2629: 2628: 2627: 2622: 2606: 2584: 2578: 2539:Protein skimmer 2477: 2468: 2464:Ultrafiltration 2444:Reverse osmosis 2424:Microfiltration 2399:Froth flotation 2339:Crystallization 2302: 2297: 2267: 2262: 2244: 2212: 2176: 2150: 2059: 2041: 2036: 2006: 2005: 2004: 1989: 1988: 1984: 1965: 1960: 1959: 1905: 1904: 1900: 1887: 1885: 1882:Wolf Foundation 1876: 1875: 1871: 1840: 1839: 1832: 1802: 1801: 1797: 1760:(6279): 87–88. 1751: 1750: 1746: 1716: 1715: 1711: 1696: 1683: 1682: 1678: 1668: 1667: 1663: 1653: 1651: 1650:on 3 March 2012 1642: 1641: 1637: 1603: 1598: 1597: 1590: 1559: 1538: 1537: 1530: 1467: 1466: 1462: 1432: 1431: 1427: 1412: 1387: 1386: 1382: 1350: 1349: 1345: 1338: 1325: 1324: 1320: 1274: 1273: 1269: 1212: 1211: 1207: 1171: 1170: 1166: 1151: 1129: 1128: 1124: 1115: 1114: 1110: 1060: 1059: 1055: 1040: 1027: 1026: 1022: 1002: 1001: 997: 987: 985: 977: 976: 969: 921: 920: 916: 909: 896: 895: 891: 884: 871: 870: 866: 859: 846: 845: 838: 831: 818: 817: 813: 803: 801: 792: 791: 787: 780: 767: 766: 762: 717:Electrophoresis 713: 712: 708: 703: 687: 656:chemoproteomics 636: 625: 620: 604: 592: 583: 555: 498: 493: 463: 395: 360: 348: 296: 271:Immunoglobulins 87: 28: 23: 22: 15: 12: 11: 5: 2657: 2655: 2647: 2646: 2644:Chromatography 2641: 2631: 2630: 2624: 2623: 2621: 2620: 2618:Unit operation 2614: 2612: 2608: 2607: 2605: 2604: 2599: 2594: 2588: 2586: 2580: 2579: 2577: 2576: 2571: 2566: 2561: 2556: 2551: 2546: 2541: 2536: 2531: 2526: 2521: 2516: 2511: 2506: 2501: 2496: 2491: 2485: 2483: 2479: 2478: 2471: 2469: 2467: 2466: 2461: 2456: 2451: 2446: 2441: 2436: 2431: 2426: 2421: 2416: 2411: 2406: 2401: 2396: 2391: 2386: 2381: 2376: 2371: 2366: 2361: 2356: 2351: 2346: 2341: 2336: 2331: 2329:Chromatography 2326: 2321: 2316: 2310: 2308: 2304: 2303: 2298: 2296: 2295: 2288: 2281: 2273: 2264: 2263: 2261: 2260: 2249: 2246: 2245: 2243: 2242: 2235: 2228: 2220: 2218: 2214: 2213: 2211: 2210: 2205: 2200: 2195: 2190: 2184: 2182: 2178: 2177: 2175: 2174: 2169: 2164: 2158: 2156: 2152: 2151: 2149: 2148: 2143: 2138: 2133: 2128: 2123: 2118: 2113: 2108: 2103: 2098: 2093: 2088: 2083: 2078: 2073: 2067: 2065: 2061: 2060: 2058: 2057: 2052: 2046: 2043: 2042: 2039:Chromatography 2037: 2035: 2034: 2027: 2020: 2012: 2003: 2002: 1997: 1991: 1990: 1979: 1978: 1977: 1976: 1971: 1964: 1963:External links 1961: 1958: 1957: 1918:(2): 636–643. 1898: 1869: 1830: 1811:(1): 138–146. 1795: 1744: 1709: 1694: 1676: 1661: 1635: 1614:(5): 593–615. 1588: 1558:978-0471140863 1557: 1528: 1460: 1425: 1410: 1380: 1361:(4): 220–222. 1343: 1336: 1318: 1267: 1205: 1164: 1149: 1122: 1108: 1053: 1039:978-1133106296 1038: 1020: 1014:10211.3/206119 995: 979:"Cube Biotech" 967: 930:(7): 920–931. 914: 907: 889: 882: 864: 857: 836: 829: 811: 785: 778: 760: 723:(2): 344–347. 705: 704: 702: 699: 686: 683: 635: 632: 623: 619: 616: 603: 600: 591: 588: 582: 579: 566:concanavalin A 554: 551: 502:protein tagged 497: 494: 462: 459: 439:immunoglobulin 394: 393:Immunoaffinity 391: 359: 356: 347: 344: 295: 292: 289: 288: 283: 278: 274: 273: 268: 259: 255: 254: 252:fusion protein 246: 241: 237: 236: 233: 228: 224: 223: 217: 212: 208: 207: 202: 197: 193: 192: 187: 182: 178: 177: 175:Polysaccharide 172: 167: 163: 162: 157: 152: 148: 147: 144: 139: 135: 134: 131: 128: 107:polyacrylamide 86: 83: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 2656: 2645: 2642: 2640: 2637: 2636: 2634: 2619: 2616: 2615: 2613: 2609: 2603: 2600: 2598: 2595: 2593: 2590: 2589: 2587: 2581: 2575: 2572: 2570: 2567: 2565: 2562: 2560: 2559:Spinning cone 2557: 2555: 2552: 2550: 2547: 2545: 2542: 2540: 2537: 2535: 2534:Mixer-settler 2532: 2530: 2527: 2525: 2522: 2520: 2517: 2515: 2512: 2510: 2507: 2505: 2502: 2500: 2497: 2495: 2492: 2490: 2487: 2486: 2484: 2480: 2475: 2465: 2462: 2460: 2457: 2455: 2452: 2450: 2449:Sedimentation 2447: 2445: 2442: 2440: 2437: 2435: 2434:Precipitation 2432: 2430: 2427: 2425: 2422: 2420: 2417: 2415: 2412: 2410: 2407: 2405: 2402: 2400: 2397: 2395: 2392: 2390: 2387: 2385: 2382: 2380: 2377: 2375: 2372: 2370: 2367: 2365: 2362: 2360: 2357: 2355: 2352: 2350: 2347: 2345: 2342: 2340: 2337: 2335: 2332: 2330: 2327: 2325: 2322: 2320: 2317: 2315: 2312: 2311: 2309: 2305: 2301: 2294: 2289: 2287: 2282: 2280: 2275: 2274: 2271: 2259: 2251: 2250: 2247: 2241: 2240: 2236: 2234: 2233: 2229: 2227: 2226: 2222: 2221: 2219: 2215: 2209: 2206: 2204: 2201: 2199: 2196: 2194: 2191: 2189: 2186: 2185: 2183: 2179: 2173: 2170: 2168: 2165: 2163: 2160: 2159: 2157: 2153: 2147: 2144: 2142: 2139: 2137: 2134: 2132: 2129: 2127: 2124: 2122: 2119: 2117: 2114: 2112: 2109: 2107: 2104: 2102: 2099: 2097: 2094: 2092: 2089: 2087: 2084: 2082: 2079: 2077: 2074: 2072: 2069: 2068: 2066: 2062: 2056: 2053: 2051: 2048: 2047: 2044: 2040: 2033: 2028: 2026: 2021: 2019: 2014: 2013: 2010: 2001: 1998: 1996: 1993: 1992: 1987: 1982: 1975: 1972: 1970: 1967: 1966: 1962: 1953: 1949: 1944: 1939: 1934: 1929: 1925: 1921: 1917: 1913: 1909: 1902: 1899: 1895: 1883: 1879: 1873: 1870: 1865: 1861: 1857: 1853: 1849: 1845: 1837: 1835: 1831: 1826: 1822: 1818: 1814: 1810: 1806: 1799: 1796: 1791: 1787: 1783: 1779: 1775: 1771: 1767: 1763: 1759: 1755: 1748: 1745: 1740: 1736: 1732: 1728: 1724: 1720: 1713: 1710: 1705: 1701: 1697: 1695:9780470087664 1691: 1687: 1680: 1677: 1672: 1665: 1662: 1649: 1645: 1639: 1636: 1631: 1627: 1622: 1617: 1613: 1609: 1602: 1595: 1593: 1589: 1584: 1580: 1576: 1572: 1568: 1564: 1560: 1554: 1550: 1546: 1542: 1535: 1533: 1529: 1524: 1520: 1515: 1510: 1506: 1502: 1497: 1492: 1488: 1484: 1480: 1476: 1472: 1464: 1461: 1456: 1452: 1448: 1444: 1440: 1436: 1429: 1426: 1421: 1417: 1413: 1407: 1403: 1399: 1395: 1391: 1384: 1381: 1376: 1372: 1368: 1364: 1360: 1356: 1355: 1347: 1344: 1339: 1337:9783662544976 1333: 1329: 1322: 1319: 1314: 1310: 1305: 1300: 1295: 1290: 1286: 1282: 1278: 1271: 1268: 1263: 1259: 1255: 1251: 1246: 1241: 1237: 1233: 1229: 1225: 1221: 1217: 1209: 1206: 1201: 1197: 1192: 1187: 1184:(5): 649–54. 1183: 1179: 1178:BioTechniques 1175: 1168: 1165: 1160: 1156: 1152: 1150:9780123745361 1146: 1142: 1138: 1134: 1126: 1123: 1118: 1112: 1109: 1104: 1100: 1096: 1092: 1088: 1084: 1080: 1076: 1072: 1068: 1064: 1057: 1054: 1049: 1045: 1041: 1035: 1031: 1024: 1021: 1015: 1010: 1006: 999: 996: 984: 980: 974: 972: 968: 963: 959: 955: 951: 946: 945:11311/1013726 941: 937: 933: 929: 925: 918: 915: 910: 908:9780124158061 904: 900: 893: 890: 885: 879: 875: 868: 865: 860: 858:9780415385114 854: 850: 843: 841: 837: 832: 830:9781588296597 826: 822: 815: 812: 799: 795: 789: 786: 781: 779:9780470087664 775: 771: 764: 761: 756: 752: 748: 744: 739: 734: 730: 726: 722: 718: 710: 707: 700: 698: 696: 692: 684: 682: 680: 676: 672: 668: 664: 659: 657: 652: 648: 644: 640: 633: 631: 629: 617: 615: 613: 609: 608:glycoproteins 601: 599: 596: 589: 587: 580: 578: 576: 572: 571:glycoproteins 567: 563: 559: 552: 550: 548: 543: 539: 535: 531: 527: 523: 519: 515: 511: 507: 503: 495: 492: 483: 479: 477: 473: 469: 460: 458: 454: 450: 448: 444: 440: 436: 431: 428: 424: 420: 415: 412: 409: 405: 399: 392: 390: 387: 384: 380: 377: 374: 368: 364: 357: 355: 351: 346:Specific uses 345: 343: 341: 335: 333: 328: 324: 320: 316: 308: 300: 293: 287: 284: 282: 279: 276: 275: 272: 269: 267: 263: 260: 257: 256: 253: 250: 247: 245: 242: 239: 238: 234: 232: 229: 226: 225: 221: 218: 216: 213: 210: 209: 206: 203: 201: 198: 195: 194: 191: 188: 186: 183: 180: 179: 176: 173: 171: 168: 165: 164: 161: 158: 156: 153: 150: 149: 145: 143: 140: 137: 136: 132: 129: 126: 125: 119: 115: 112: 108: 104: 100: 96: 92: 84: 82: 80: 76: 72: 68: 64: 60: 56: 52: 48: 44: 40: 36: 32: 19: 2519:Filter press 2504:Depth filter 2394:Flocculation 2364:Distillation 2237: 2230: 2223: 2070: 1985: 1915: 1911: 1901: 1893: 1886:. Retrieved 1881: 1872: 1847: 1843: 1808: 1804: 1798: 1757: 1753: 1747: 1722: 1718: 1712: 1685: 1679: 1670: 1664: 1652:. Retrieved 1648:the original 1638: 1611: 1607: 1540: 1478: 1474: 1463: 1438: 1434: 1428: 1393: 1383: 1358: 1352: 1346: 1327: 1321: 1284: 1280: 1270: 1245:10138/321264 1219: 1215: 1208: 1181: 1177: 1167: 1132: 1125: 1111: 1070: 1066: 1056: 1030:Biochemistry 1029: 1023: 1004: 998: 988:11 September 986:. Retrieved 983:Cube Biotech 982: 927: 923: 917: 898: 892: 873: 867: 848: 820: 814: 804:14 September 802:. Retrieved 797: 788: 769: 763: 720: 716: 709: 695:Meir Wilchek 688: 660: 642: 638: 637: 621: 605: 593: 584: 556: 506:Protein tags 499: 464: 455: 451: 432: 416: 413: 400: 396: 388: 385: 381: 378: 369: 365: 361: 352: 349: 336: 329: 325: 321: 317: 313: 185:Nucleic acid 116: 91:mobile phase 88: 71:nucleic acid 30: 29: 2494:Belt filter 2459:Sublimation 2349:Decantation 1654:29 November 1222:: 160–168. 798:bio-rad.com 738:1874/362143 628:thiocyanate 514:glutathione 244:Glutathione 75:selectivity 35:biomolecule 2633:Categories 2583:Multiphase 2514:Evaporator 2499:Centrifuge 2389:Filtration 2384:Extraction 2324:Adsorption 2314:Absorption 2064:Techniques 1725:(1): 5–8. 1073:: 107653. 701:References 675:chaperones 665:targets – 489:See also: 441:-specific 427:sulfhydryl 411:antibody. 281:Nickel-NTA 231:Calmodulin 79:resolution 2597:Azeotrope 2307:Processes 1782:0028-0836 1739:1879-1468 1704:420027217 1567:1934-3663 1505:0027-8424 1262:203147714 1103:226276355 1087:0734-9750 1048:777722371 962:205492204 667:proteases 581:Specialty 575:glycoform 547:imidazole 522:Histidine 476:imidazole 447:Protein G 443:Protein A 266:Protein G 262:Protein A 85:Principle 55:substrate 2611:Concepts 2602:Eutectic 2554:Scrubber 2529:Leachate 2409:Leaching 2354:Dialysis 2258:Category 2050:software 1888:17 March 1864:23806099 1825:21352794 1630:10222345 1575:18429210 1523:28607052 1455:11694288 1420:25749956 1375:15149073 1313:32893620 1254:31679569 1200:18474040 1159:19892188 1095:33157154 954:26992151 755:33657660 747:28905402 423:cysteine 419:antigens 205:Receptor 155:Antibody 146:Enzymes 101:such as 59:receptor 47:antibody 2585:systems 2482:Devices 2429:Osmosis 2055:history 1952:4971842 1920:Bibcode 1790:4306269 1762:Bibcode 1583:3197260 1514:5495267 1483:Bibcode 1304:7586295 1224:Bibcode 685:History 671:kinases 663:protein 630:(SCN). 562:lectins 553:Lectins 518:maltose 200:Hormone 160:Antigen 127:Sr. no 103:agarose 99:polymer 67:protein 43:antigen 2369:Drying 2181:Theory 1983:about 1950:  1943:225207 1940:  1862:  1823:  1788:  1780:  1754:Nature 1737:  1702:  1692:  1628:  1581:  1573:  1565:  1555:  1521:  1511:  1503:  1453:  1418:  1408:  1373:  1334:  1311:  1301:  1260:  1252:  1198:  1157:  1147:  1101:  1093:  1085:  1046:  1036:  960:  952:  905:  880:  855:  827:  776:  753:  745:  558:Lectin 538:copper 530:cobalt 526:nickel 332:eluted 220:Biotin 215:Avidin 170:Lectin 63:ligand 51:enzyme 2564:Still 1786:S2CID 1604:(PDF) 1579:S2CID 1258:S2CID 1099:S2CID 958:S2CID 751:S2CID 472:elute 433:Most 65:, or 1948:PMID 1890:2021 1860:PMID 1821:PMID 1778:ISSN 1735:ISSN 1700:OCLC 1690:ISBN 1656:2010 1626:PMID 1571:PMID 1563:ISSN 1553:ISBN 1519:PMID 1501:ISSN 1451:PMID 1416:PMID 1406:ISBN 1371:PMID 1332:ISBN 1309:PMID 1250:PMID 1220:1091 1196:PMID 1155:PMID 1145:ISBN 1091:PMID 1083:ISSN 1044:OCLC 1034:ISBN 990:2019 950:PMID 903:ISBN 878:ISBN 853:ISBN 825:ISBN 806:2020 774:ISBN 743:PMID 693:and 677:and 542:iron 540:and 534:zinc 408:tris 77:and 69:and 61:and 53:and 45:and 1938:PMC 1928:doi 1852:doi 1813:doi 1809:414 1770:doi 1758:346 1727:doi 1616:doi 1545:doi 1509:PMC 1491:doi 1479:114 1443:doi 1398:doi 1363:doi 1299:PMC 1289:doi 1240:hdl 1232:doi 1186:doi 1137:doi 1075:doi 1009:hdl 940:hdl 932:doi 733:hdl 725:doi 643:WAC 512:), 510:His 445:or 277:10 264:or 249:GST 105:or 2635:: 1946:. 1936:. 1926:. 1916:61 1914:. 1910:. 1892:. 1880:. 1858:. 1848:85 1846:. 1833:^ 1819:. 1807:. 1784:. 1776:. 1768:. 1756:. 1733:. 1723:11 1721:. 1698:. 1624:. 1612:45 1610:. 1606:. 1591:^ 1577:. 1569:. 1561:. 1551:. 1531:^ 1517:. 1507:. 1499:. 1489:. 1477:. 1473:. 1449:. 1439:49 1437:. 1414:. 1404:. 1369:. 1359:82 1357:. 1307:. 1297:. 1285:92 1283:. 1279:. 1256:. 1248:. 1238:. 1230:. 1218:. 1194:. 1182:44 1180:. 1176:. 1153:. 1143:. 1097:. 1089:. 1081:. 1071:45 1069:. 1065:. 1042:. 981:. 970:^ 956:. 948:. 938:. 928:11 926:. 839:^ 796:. 749:. 741:. 731:. 721:39 719:. 697:. 673:, 669:, 614:. 536:, 532:, 528:, 478:. 404:pH 258:9 240:8 227:7 211:6 196:5 181:4 166:3 151:2 138:1 57:, 49:, 2292:e 2285:t 2278:v 2031:e 2024:t 2017:v 1954:. 1930:: 1922:: 1866:. 1854:: 1827:. 1815:: 1792:. 1772:: 1764:: 1741:. 1729:: 1706:. 1658:. 1632:. 1618:: 1585:. 1547:: 1525:. 1493:: 1485:: 1457:. 1445:: 1422:. 1400:: 1377:. 1365:: 1340:. 1315:. 1291:: 1264:. 1242:: 1234:: 1226:: 1202:. 1188:: 1161:. 1139:: 1119:. 1105:. 1077:: 1050:. 1017:. 1011:: 992:. 964:. 942:: 934:: 911:. 886:. 861:. 833:. 808:. 782:. 757:. 735:: 727:: 641:( 624:2 20:)

Index

Affinity Chromatography
biomolecule
macromolecular binding
antigen
antibody
enzyme
substrate
receptor
ligand
protein
nucleic acid
selectivity
resolution
mobile phase
stationary phase
polymer
agarose
polyacrylamide
functional groups
Substrate analogue
Antibody
Antigen
Lectin
Polysaccharide
Nucleic acid
Complementary base sequence
Hormone
Receptor
Avidin
Biotin

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑